Diagnostic accuracy of pelvis multiparametric MRI against CT virtual hysterosalpingography: a prospective study of tubal patency through female infertility assessment.
Journal
The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
pmc-release:
01
06
2024
medline:
22
5
2023
pubmed:
18
4
2023
entrez:
17
4
2023
Statut:
ppublish
Résumé
To evaluate the diagnostic accuracy of MRI-hysterosalpingogram (HSG) with semiquantitative dynamic contrast-enhanced perfusion, against the virtual multislice CT hysterosalpingogram (VHSG) as a reference standard. In this prospective study, 26 women (age >18 years) searching for infertility causes and with VHSG physician request. Thereafter, the assessment performance of both techniques was determined by two reader analyses. k statistics were used for the assessment of tubal patency. Receiver operating characteristic (ROC) analysis was used to compare the capability for tubal patency assessment between both exams on a per-patient and per-tube basis. The McNemar test was used to compare the diagnostic accuracy measures. Tubal patency, uterine morphological, ovarian, and extrauterine abnormalities were evaluated through both exams in all 26 women. There was no significant difference between diagnostic performance measurements between the methods. The ROC curve of VHSG was 0.852 for both per-patient and per-tube analyses, and one and 0.938 for MRI-HSG. Sensitivity and specificity for per-patient and per-tube for VHSG were 95.2 and 97.7, 80 and 87.5%, and for MRI-HSG 100% for both analyses and 100 and 87.5%, respectively. This study demonstrates the feasibility of diagnosing tubal patency through MRI, using a semi-quantitative dynamic contrast-enhanced perfusion sequence, and the satisfactory diagnosing of the uterine morphology, ovarian abnormalities, and ovarian and deep endometriosis. Multiparametric MRI with a perfusion real-time sequence as a HSG method can be used in the evaluation not only for uterine and ovarian abnormilities but also tubal patency.
Identifiants
pubmed: 37066809
doi: 10.1259/bjr.20220889
pmc: PMC10230390
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20220889Références
Curr Urol Rep. 2019 Nov 16;20(11):77
pubmed: 31734736
Acta Radiol. 2016 Sep;57(9):1132-9
pubmed: 26663038
Indian J Radiol Imaging. 2019 Apr-Jun;29(2):163-167
pubmed: 31367087
Fertil Steril. 2016 Jun;105(6):1403-1420.e7
pubmed: 27140290
Acta Radiol. 2020 Jul;61(7):1001-1007
pubmed: 31684746
Acta Radiol. 2010 Jul;51(6):693-701
pubmed: 20482222
Radiographics. 2010 May;30(3):643-61
pubmed: 20462986
Biometrics. 1977 Jun;33(2):363-74
pubmed: 884196
Eur Radiol. 2001;11(8):1439-44
pubmed: 11519555
Health Technol Assess. 2007 Dec;11(50):iii, ix-51
pubmed: 18021577
Clin Biochem. 2018 Dec;62:2-10
pubmed: 29555319
Fertil Steril. 2015 May;103(5):1136-43
pubmed: 25934599
Eur Radiol. 2019 Feb;29(2):501-508
pubmed: 29974219
Hum Reprod Update. 2015 Jul-Aug;21(4):411-26
pubmed: 25801630
Radiographics. 2006 Mar-Apr;26(2):419-31
pubmed: 16549607
Fertil Steril. 2008 Nov;90(5):1953-8
pubmed: 18222438
Am J Obstet Gynecol. 1999 Oct;181(4):952-7
pubmed: 10521760
AJR Am J Roentgenol. 2008 Nov;191(5):1381-5
pubmed: 18941073
Radiol Clin North Am. 2020 Mar;58(2):215-225
pubmed: 32044003
J Magn Reson Imaging. 2018 Nov;48(5):1336-1343
pubmed: 29624774
Obstet Gynecol. 2019 Jun;133(6):1294-1295
pubmed: 31135761
Hum Reprod. 2002 Dec;17(12):3138-41
pubmed: 12456613